Approvals/TGA/XOLAIR omalizumab (rch) 75 mg solution for injection pre-filled syringe

Approved

STANDARD

XOLAIR omalizumab (rch) 75 mg solution for injection pre-filled syringe

Approval Id: 41df034a7e4bcd17
Product Name: XOLAIR omalizumab (rch) 75 mg solution for injection pre-filled syringe
Artg Id: 201124
Artg Name: XOLAIR omalizumab (rch) 75 mg solution for injection pre-filled syringe
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date: 2013-08-19
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/1e4737624f1cc4403a9f94950f01e4d6.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/13cfbe8c8418e9d2e42d9eeb9686aaf6.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

41df034a7e4bcd17

Type

Standard